JING RUEY JOANNA YEH

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi A Wnt inhibitor with a twist
    Jing Ruey J Yeh
    Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
    Chem Biol 18:1518-20. 2011
  2. ncbi AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression
    Jing Ruey J Yeh
    Developmental Biology Laboratory, Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA
    Development 135:401-10. 2008
  3. ncbi Zebrafish small molecule screen in reprogramming/cell fate modulation
    Jing Ruey J Yeh
    Developmental Biology Laboratory, Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA
    Methods Mol Biol 636:317-27. 2010
  4. ncbi Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival
    Farshid Dayyani
    Department of Pediatrics, Division of Pediatric Hematology Oncology, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA
    Blood 111:4338-47. 2008
  5. ncbi Identification of a novel retinoid by small molecule screening with zebrafish embryos
    Chetana Sachidanandan
    Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, United States of America
    PLoS ONE 3:e1947. 2008
  6. ncbi Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs
    Lindsay Cade
    Cardiovascular Research Center, Massachusetts General Hospital, Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA
    Nucleic Acids Res 40:8001-10. 2012
  7. ncbi Chemical genetics: adding to the developmental biology toolbox
    Jing-Ruey J Yeh
    Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 06520, USA
    Dev Cell 5:11-9. 2003
  8. ncbi Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest
    Jing Ruey J Yeh
    Department of Molecular, Yale University, New Haven, CT 06520 8103, USA
    Proc Natl Acad Sci U S A 103:10379-84. 2006

Research Grants

  1. Discovering chemical tools for acute myelogenous leukemia
    JING RUEY JOANNA YEH; Fiscal Year: 2010

Collaborators

  • Yi Zhang
  • Randall T Peterson
  • Lindsay Cade
  • Farshid Dayyani
  • Chetana Sachidanandan
  • Cyd Khayter
  • Samir Patel
  • Jeffry D Sander
  • Woong Y Hwang
  • Deepak Reyon
  • J Keith Joung
  • Shengdar Q Tsai
  • Quinn P Peterson
  • Eun-Young Ahn
  • Dong Er Zhang
  • Dong-Er Zhang
  • Irwin D Bernstein
  • David A Sweetser
  • Eun Young Ahn
  • Jianfeng Wang
  • Erica Tobey

Detail Information

Publications8

  1. ncbi A Wnt inhibitor with a twist
    Jing Ruey J Yeh
    Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
    Chem Biol 18:1518-20. 2011
    ..this issue of Chemistry & Biology)...
  2. ncbi AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression
    Jing Ruey J Yeh
    Developmental Biology Laboratory, Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA
    Development 135:401-10. 2008
    ..Thus, this zebrafish model facilitates in vivo dissection of AML1-ETO-mediated signaling, and will enable large-scale chemical screens to identify suppressors of the in vivo effects of AML1-ETO...
  3. ncbi Zebrafish small molecule screen in reprogramming/cell fate modulation
    Jing Ruey J Yeh
    Developmental Biology Laboratory, Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA
    Methods Mol Biol 636:317-27. 2010
    ..The methods discussed herein may be broadly applicable for identifying small molecules that modulate other cell fate decisions...
  4. ncbi Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival
    Farshid Dayyani
    Department of Pediatrics, Division of Pediatric Hematology Oncology, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA
    Blood 111:4338-47. 2008
    ..This study is the first to implicate the TLEs as potential tumor suppressor genes in myeloid leukemia...
  5. ncbi Identification of a novel retinoid by small molecule screening with zebrafish embryos
    Chetana Sachidanandan
    Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, United States of America
    PLoS ONE 3:e1947. 2008
    ....
  6. ncbi Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs
    Lindsay Cade
    Cardiovascular Research Center, Massachusetts General Hospital, Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA
    Nucleic Acids Res 40:8001-10. 2012
    ..Our results suggest that construction of one to two heterodimeric TALEN pairs for any given gene will, in most cases, enable researchers to rapidly generate knockout zebrafish...
  7. ncbi Chemical genetics: adding to the developmental biology toolbox
    Jing-Ruey J Yeh
    Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 06520, USA
    Dev Cell 5:11-9. 2003
    ..New uses for old teratogens as well as novel chemical modulators of development have begun to fill this void...
  8. ncbi Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest
    Jing Ruey J Yeh
    Department of Molecular, Yale University, New Haven, CT 06520 8103, USA
    Proc Natl Acad Sci U S A 103:10379-84. 2006
    ..Together, these results demonstrate an essential role for MetAP-2 in angiogenesis and indicate that MetAP-2 is responsible for the endothelial cell growth arrest induced by Fg and its derivatives...

Research Grants2

  1. Discovering chemical tools for acute myelogenous leukemia
    JING RUEY JOANNA YEH; Fiscal Year: 2010
    ..The primary objective of these studies is discovery and validation of new therapeutic techniques for treating leukemia. ..